Pursglove Geordan Garrett has filed 4 insider transactions across 2 companies since July 2025.
Most recent transaction: a grant/award of 350000 shares of LIXTE BIOTECHNOLOGY HOLDINGS, INC. ($LIXT) on April 15, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 15, 2026 | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | $LIXT | Pursglove Geordan Garrett | CEO and Chairman of the Board | A | Common Stock | 350000 | $0.00 | 350,000.0000 | 6,171,195 | 9999.99% | 5.67% |
| April 15, 2026 | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | $LIXT | Pursglove Geordan Garrett | CEO and Chairman of the Board | D | Options to Purchase Common Stock | 350000 | $0.00 | 0.0000 | 6,171,195 | 100.00% | 5.67% |
| Jan. 1, 2026 | GridAI Technologies Corp. | $GRDX | Pursglove Geordan Garrett | Director | A | Common Stock | 40000 | $0.00 | 40,000.0000 | 1,652,679 | 9999.99% | 2.42% |
| July 3, 2025 | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | $LIXT | Pursglove Geordan Garrett | CEO and Chairman of the Board | A | Options to Purchase Common Stock | 350000 | $0.00 | 350,000.0000 | 2,249,290 | 9999.99% | 15.56% |